Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema

Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema

Aims. To investigate the correlations between renal biomarkers and the treatment outcomes of ranibizumab for diabetic macular edema (DME). Methods. This hospital-based study retrospectively enrolled 88 eyes from 67 patients who had received one-year intravitreal ranibizumab treatment for DME. Best-c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ivan Pochou Lai, Wei-Lun Huang, Chung-May Yang, Chang-Hao Yang, Tzyy-Chang Ho, Yi-Ting Hsieh
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2020/7239570
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
by: Ali Demircan, et al.
Published: (2018-01-01)

Comparison of Perioperative Ranibizumab Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery
by: Erhan Yumuşak, et al.
Published: (2016-01-01)

Submacular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema
by: Samir M. El-Baha, et al.
Published: (2019-01-01)

Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting
by: Anne-Laurence Best, et al.
Published: (2018-01-01)

Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study)
by: Ugo Menchini, et al.
Published: (2015-01-01)

Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
by: Xiaolei Sun, et al.
Published: (2020-01-01)

Effectiveness of Intravitreal Ranibizumab in Nonvitrectomized and Vitrectomized Eyes with Diabetic Macular Edema: A Two-Year Retrospective Analysis
by: Ozgun Melike Gedar Totuk, et al.
Published: (2020-01-01)

Combination therapy of intravitreal ranibizumab and sub-tenon triamcinolone for treatment of resistant diabetic macular edema: a clinical study in Egypt
by: Hossam Eldin M. A. Khalil, et al.
Published: (2025-01-01)

Erratum: Ultrastructural imaging biomarkers in diabetic macular edema: A major review
Published: (2025-02-01)

Optical Coherence Tomography (Angiography) Biomarkers in the Assessment and Monitoring of Diabetic Macular Edema
by: Corina-Iuliana Suciu, et al.
Published: (2020-01-01)

Correlation between Imaging Morphological Findings and Laboratory Biomarkers in Patients with Diabetic Macular Edema
by: Eleni Dimitriou, et al.
Published: (2021-01-01)

Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease
by: Ning-Yi Hsia, et al.
Published: (2021-01-01)

Secondary Full-thickness Macular Holes after Diabetic Vitrectomy: Clinical Manifestations and Rational Approaches to the Treatment
by: Yun Hsia, et al.
Published: (2022-01-01)

Quantitative Analysis of Retinal Microvascular Perfusion and Novel Biomarkers of the Treatment Response in Diabetic Macular Edema
by: Young Gun Park, et al.
Published: (2020-01-01)

New Strategies for Treatment of Diabetic Macular Edema
by: Yoshihiro Takamura, et al.
Published: (2018-01-01)

Intravitreal Therapy for Diabetic Macular Edema: An Update
by: Claudio Furino, et al.
Published: (2021-01-01)

Correlating the Optical Coherence Tomography Patterns and Biomarkers of Diabetic Macular Edema with Hemoglobin Level in Diabetic Kidney Disease
by: Gopalakrishnan N, et al.
Published: (2025-01-01)

Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema
by: Ningxin Dou, et al.
Published: (2021-01-01)

Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
by: Pedro Romero-Aroca, et al.
Published: (2016-01-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Cystoid Macular Edema in Bietti's Crystalline Retinopathy
by: Ali Osman Saatci, et al.
Published: (2014-01-01)

Systemic Factors Associated with Treatment Response in Diabetic Macular Edema
by: Wendy Meihua Wong, et al.
Published: (2020-01-01)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01)

The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials
by: Li Xiaodong, et al.
Published: (2022-01-01)

Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
by: Andrea Russo, et al.
Published: (2013-01-01)

Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes
by: Sigrid Freissinger, et al.
Published: (2020-01-01)

Analysis of the Cytokine Expression in the Aqueous Humor of Individuals with BRVO-Associated Macular Edema
by: Chengyi Zhu, et al.
Published: (2022-01-01)

Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
by: Laura N. Distefano, et al.
Published: (2017-01-01)

Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence
by: Bogumiła Sędziak-Marcinek, et al.
Published: (2021-01-01)

Restoration of Foveal Bulge after Resolution of Diabetic Macular Edema with Coexisting Serous Retinal Detachment
by: Yijun Hu, et al.
Published: (2020-01-01)

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
by: Zongyi Wang, et al.
Published: (2020-01-01)

Pengaruh Bevacizumab Intravitreal terhadap Best Corrected Visual Acuity dan Central Macular Thickness pada Diabetic Macular Edema
by: Arini Ghaisa Atsari, et al.
Published: (2020-01-01)

Multifocal electroretinogram evaluation of different optical coherence tomography patterns of diabetic macular edema
by: Abdelrahman W.M. Mohamed, et al.
Published: (2025-01-01)

Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01)

Application of deep learning algorithm for judicious use of anti-VEGF in diabetic macular edema
by: Anwesa Mondal, et al.
Published: (2025-02-01)

Direct Photocoagulation Guided by Merged Retinal Images for the Treatment of Focal Diabetic Macular Edema
by: Yoshihiro Takamura, et al.
Published: (2018-01-01)

Evaluation of Navigated Laser Photocoagulation (Navilas 577+) for the Treatment of Refractory Diabetic Macular Edema
by: Fusae Kato, et al.
Published: (2018-01-01)

Association between Visual Acuity and Retinal Layer Metrics in Diabetics with and without Macular Edema
by: LakshmiPriya Rangaraju, et al.
Published: (2018-01-01)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01)

Severe Macular Edema in Patients with Juvenile Idiopathic Arthritis-Related Uveitis
by: Maria Pia Paroli, et al.
Published: (2013-01-01)